Reperfusion data acquisition method for myocardial angiography quantitative analysis and ultrasonic imaging system
By automatically determining the starting point of microbubble crushing and the starting point of reperfusion in the quantitative analysis of contrast agent in myocardial contrast, the problem of phase non-standardization during reperfusion data is solved, and the consistency of myocardial perfusion evaluation and the simplicity of data fitting are improved. .
Patent Information
- Application Number
- CN202310658959.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-05
- Publication Date
- 2024-12-06
AI Technical Summary
The phase is not standardized during reperfusion data in the prior art central myosography quantitative analysis, resulting in difficult to set the crushing time and inconvenient operation, which affects the accuracy and consistency of data fitting.
By acquiring electrocardiogram data, the starting point of contrast agent microbubble crushing and the starting point of myocardial reperfusion are located in the time phase of the cardiac cycle, and the ultrasonic probe is controlled to perform corresponding ultrasonic emission and reception, generate reperfusion data, and simplify the data fitting process. .
The standardization of reperfusion data is achieved, which improves the consistency of myocardial perfusion evaluation and the simplicity of data fitting, and reduces the complexity of user operations.
Smart Images

Figure CN119074056A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of ultrasonic imaging, and in particular to a reperfusion data acquisition method and an ultrasonic imaging system for quantitative analysis of myocardial contrast imaging. Background Art
[0002] In the study of myocardial perfusion, the normality of myocardial tissue perfusion can be used to determine whether the oxygen supply to muscle cells is sufficient. Under normal physiological conditions, the tissue's demand for oxygen determines the tissue's blood flow. Therefore, blood flow is an important parameter for determining heart disease. Currently, microvascular perfusion detection based on contrast agents is the most direct and accurate method for assessing myocardial perfusion.
[0003] Myocardial angiography focuses on the process of crushing and reperfusion. Quantitative analysis of myocardial angiography is to select ROI in the two-dimensional myocardial angiography image, draw the time intensity curve within the ROI, and use the formula C(t) = A×(1-e^ (-βt) ) were fitted, and the model parameters A, β, and A×β obtained by fitting were used to quantitatively evaluate the myocardial perfusion level.
[0004] However, the reperfusion data used for quantitative analysis of myocardial contrast imaging has not been standardized in terms of phase. This is mainly reflected in the fact that the cardiac phase of the starting point of reperfusion after the contrast agent microbubble is crushed is not fixed. Therefore, on the one hand, the difference in reperfusion caused by the phase is introduced between different cases. On the other hand, due to the different myocardial blood volumes in diastole and systole, the reasonable crushing time required in different phases is different. The phase difference will make it difficult to set the crushing time. In addition, in the post-processing process, for the curve fitting in the quantitative analysis of myocardial contrast imaging, it is necessary to select the data segment of reperfusion after crushing for fitting, and hope that the analysis process is as simple as possible. However, since the reperfusion data has not been standardized in terms of phase, users often need to manually set the fitting start and end points in the overall movie data, which is inconvenient to operate. Summary of the invention
[0005] A series of simplified concepts are introduced in the Summary of the Invention, which will be further described in detail in the Detailed Description of the Invention. The Summary of the Invention does not mean to attempt to define the key features and essential technical features of the claimed technical solution, nor does it mean to attempt to determine the scope of protection of the claimed technical solution.
[0006] A first aspect of an embodiment of the present application provides a method for acquiring reperfusion data for quantitative analysis of myocardial contrast imaging, which is applied to an ultrasound imaging system, wherein the myocardium contains contrast agent microbubbles, and the ultrasound imaging system includes an ultrasound probe and a processor, wherein the steps executed by the processor include: acquiring electrocardiogram data, and determining the cardiac cycle based on the electrocardiogram data; determining the time phase in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the time phase corresponding to the characteristic point of the R wave of the cardiac cycle; when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubbles, until the current moment reaches the time phase corresponding to the myocardial reperfusion starting point; controlling the ultrasound probe to transmit a second ultrasound wave to the myocardium and receiving a returned second ultrasound echo signal; and generating reperfusion data based on the second ultrasound echo signal.
[0007] A second aspect of an embodiment of the present application provides a method for acquiring reperfusion data for quantitative analysis of myocardial contrast imaging, which is applied to an ultrasound imaging system, wherein the myocardium contains contrast agent microbubbles, and the ultrasound imaging system includes an ultrasound probe and a processor, wherein the steps executed by the processor include: acquiring electrocardiogram data; when the first characteristic peak of the electrocardiogram data is reached at the current moment, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles, until the kth characteristic peak of the electrocardiogram data is reached at the current moment, wherein k is a natural number and k is greater than 1; controlling the ultrasound probe to transmit a second ultrasound wave to the myocardium and receiving a returned second ultrasound echo signal; and determining the reperfusion data based on the second ultrasound echo signal.
[0008] A third aspect of an embodiment of the present application provides a method for acquiring reperfusion data for quantitative analysis of myocardial contrast imaging, which is applied to an ultrasound imaging system, wherein the myocardium contains contrast agent microbubbles, and the ultrasound imaging system includes an ultrasound probe and a processor, wherein the steps executed by the processor include: acquiring electrocardiogram data; controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium at any time to break up the contrast agent microbubbles until the time phase corresponding to the starting point of myocardial reperfusion is reached at the current time; controlling the ultrasound probe to transmit a second ultrasound wave to the myocardium and receiving a returned second ultrasound echo signal; and determining the reperfusion data based on the second ultrasound echo signal.
[0009] A fourth aspect of an embodiment of the present application provides a method for acquiring reperfusion data for quantitative analysis of myocardial contrast imaging, which is applied to an ultrasound imaging system, wherein the myocardium contains contrast agent microbubbles, the ultrasound imaging system comprises an ultrasound probe, a processor and a display, the display interface of the display comprises a microbubble crushing control, and the steps executed by the processor comprise: acquiring electrocardiogram data, and determining the cardiac cycle based on the electrocardiogram data; determining the phase in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle; in response to the operation of the microbubble crushing control, when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubbles, until the current moment reaches the phase corresponding to the myocardial reperfusion starting point; controlling the ultrasound probe to transmit a second ultrasound wave to the myocardium and receiving a returned second ultrasound echo signal; and generating reperfusion data based on the second ultrasound echo signal.
[0010] The fifth aspect of an embodiment of the present application provides an ultrasound imaging system, comprising: an ultrasound probe; a transmitting circuit for stimulating the ultrasound probe to transmit ultrasound to a target tissue; a receiving circuit for controlling the ultrasound probe to receive the echo of the ultrasound to obtain the echo signal of the ultrasound; and a processor for executing the steps of the reperfusion data acquisition method for quantitative analysis of myocardial angiography as described above.
[0011] According to the reperfusion data acquisition method and ultrasound imaging system for quantitative analysis of myocardial contrast provided in the present application, the reperfusion data is automatically determined by automatically determining the phase of the cardiac cycle in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located, which facilitates subsequent data fitting and improves the consistency of evaluating myocardial perfusion. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] The following drawings of the present invention are used to understand the present invention as part of the present invention. The embodiments of the present invention are shown in the drawings and the description thereof is used to explain the principle of the present invention.
[0013] In the attached figure:
[0014] Figure 1 A schematic block diagram of an ultrasound imaging system according to an embodiment of the present application is shown;
[0015] Figure 2 A flow chart of a method for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application is shown;
[0016] Figure 3AA schematic diagram of an electrocardiogram according to an embodiment of the present application is shown, and a contrast agent microbubble crushing start point and a myocardial reperfusion start point are marked in the electrocardiogram;
[0017] Figure 3B A schematic diagram of an electrocardiogram according to an embodiment of the present application is shown, and a contrast agent microbubble crushing start point and a myocardial reperfusion start point are marked in the electrocardiogram;
[0018] Figure 4 A flow chart of a method for acquiring reperfusion data for quantitative analysis of myocardial angiography according to another embodiment of the present application is shown;
[0019] Figure 5 A schematic diagram of an electrocardiogram according to another embodiment of the present application is shown, and a contrast agent microbubble crushing start point and a myocardial reperfusion start point are marked in the electrocardiogram;
[0020] Figure 6 A flow chart of a method for acquiring reperfusion data for quantitative analysis of myocardial angiography according to another embodiment of the present application is shown;
[0021] Figure 7 A schematic diagram of an electrocardiogram according to another embodiment of the present application is shown, and a contrast agent microbubble crushing start point and a myocardial reperfusion start point are marked in the electrocardiogram;
[0022] Figure 8 A schematic diagram of reperfusion data according to an embodiment of the present application is shown. DETAILED DESCRIPTION
[0023] In the following description, a large number of specific details are provided to provide a more thorough understanding of the present invention. However, it is apparent to those skilled in the art that the present invention can be implemented without one or more of these details. In other examples, in order to avoid confusion with the present invention, some technical features well known in the art are not described.
[0024] It should be understood that the present invention can be implemented in different forms and should not be construed as being limited to the embodiments presented herein. On the contrary, providing these embodiments will make the disclosure thorough and complete and fully convey the scope of the present invention to those skilled in the art. In the accompanying drawings, the sizes and relative sizes of layers and regions may be exaggerated for clarity. The same reference numerals throughout represent the same elements.
[0025] The purpose of the terms used herein is only to describe specific embodiments and is not intended to be limiting of the present invention. When used herein, the singular forms "one", "an" and "said / the" are also intended to include plural forms, unless the context clearly indicates otherwise. It should also be understood that the terms "consisting of" and / or "comprising", when used in this specification, determine the presence of the features, integers, steps, operations, elements and / or parts, but do not exclude the presence or addition of one or more other features, integers, steps, operations, elements, parts and / or groups. When used herein, the term "and / or" includes any and all combinations of the relevant listed items.
[0026] In order to fully understand the present invention, detailed steps and detailed structures will be presented in the following description to illustrate the technical solution proposed by the present invention. The preferred embodiments of the present invention are described in detail below, but in addition to these detailed descriptions, the present invention may also have other implementations.
[0027] Next, first refer to Figure 1 An ultrasound imaging system according to an embodiment of the present application is described. Figure 1 A schematic structural block diagram of an ultrasound imaging system 100 according to an embodiment of the present application is shown.
[0028] like Figure 1 As shown, the ultrasound imaging system 100 includes an ultrasound probe 110, a transmitting circuit 112, a receiving circuit 114, a processor 116, and a display 118. Further, the ultrasound imaging system may also include a transmit / receive selection switch 120 and a beamforming module 122, and the transmitting circuit 112 and the receiving circuit 114 may be connected to the ultrasound probe 110 through the transmit / receive selection switch 120.
[0029] The ultrasonic probe 110 includes a plurality of transducer array elements, which can be arranged in a row to form a linear array, or arranged in a two-dimensional matrix to form a surface array, or a plurality of transducer array elements can also form a convex array. The transducer array element is used to transmit ultrasonic waves according to the excitation electrical signal, or to convert the received ultrasonic waves into electrical signals, so each transducer array element can be used to realize the mutual conversion between the electrical pulse signal and the ultrasonic wave, so as to realize the transmission of ultrasonic waves to the tissue of the target area of the object to be tested, and can also be used to receive the ultrasonic wave echo reflected by the tissue. When performing ultrasonic detection, which transducer array elements are used to transmit ultrasonic waves and which transducer array elements are used to receive ultrasonic waves can be controlled by the transmission sequence and the reception sequence, or the transducer array elements can be controlled to transmit ultrasonic waves or receive ultrasonic wave echoes in time slots. The transducer array elements participating in ultrasonic wave transmission can be excited by electrical signals at the same time, so as to transmit ultrasonic waves at the same time; or, the transducer array elements participating in ultrasonic wave beam transmission can also be excited by several electrical signals with a certain time interval, so as to continuously transmit ultrasonic waves with a certain time interval.
[0030] During the ultrasonic imaging process, the transmitting circuit 112 sends the delayed focused transmitting pulse to the ultrasonic probe 110 through the transmitting / receiving selection switch 120. The ultrasonic probe 110 is stimulated by the transmitting pulse to transmit an ultrasonic beam to the tissue of the target area of the object to be measured, and receives the ultrasonic echo with tissue information reflected from the tissue of the target area after a certain delay, and reconverts the ultrasonic echo into an electrical signal. The receiving circuit 114 receives the electrical signal converted and generated by the ultrasonic probe 110, obtains the ultrasonic echo signal, and sends these ultrasonic echo signals to the beamforming module 122, which performs focusing delay, weighting and channel summing on the ultrasonic echo data, and then sends them to the processor 116. The processor 116 performs signal detection, signal enhancement, data conversion, logarithmic compression and other processing on the ultrasonic echo signal to form an ultrasonic image. The ultrasonic image obtained by the processor 116 can be displayed on the display 118 or stored in the memory 124.
[0031] Optionally, the processor 116 may be implemented as software, hardware, firmware or any combination thereof, and may use a single or multiple application specific integrated circuits (ASICs), a single or multiple general purpose integrated circuits, a single or multiple microprocessors, a single or multiple programmable logic devices, or any combination of the aforementioned circuits and / or devices, or other suitable circuits or devices. Furthermore, the processor 116 may control other components in the ultrasound imaging system 100 to perform the corresponding steps of the methods in various embodiments of the present specification.
[0032] The display 118 is connected to the processor 116, and the display 118 may be a touch screen, a liquid crystal display, etc.; or, the display 118 may be an independent display such as a liquid crystal display, a television, etc., which is independent of the ultrasound imaging system 100; or, the display 118 may be a display screen of an electronic device such as a smart phone or a tablet computer, etc. The number of the display 118 may be one or more.
[0033] The display 118 can display the ultrasound image obtained by the processor 116. In addition, while displaying the ultrasound image, the display 118 can also provide the user with a graphical interface for human-computer interaction. One or more controlled objects are set on the graphical interface, and the user is provided with a human-computer interaction device to input operation instructions to control these controlled objects, thereby performing corresponding control operations. For example, an icon is displayed on the graphical interface, and the icon can be operated by the human-computer interaction device to perform a specific function, such as drawing a region of interest box on the ultrasound image.
[0034] Optionally, the ultrasound imaging system 100 may further include other human-machine interaction devices in addition to the display 118, which are connected to the processor 116. For example, the processor 116 may be connected to the human-machine interaction device via an external input / output port, and the external input / output port may be a wireless communication module, or a wired communication module, or a combination of the two. The external input / output port may also be implemented based on USB, bus protocols such as CAN, and / or wired network protocols.
[0035] The human-computer interaction device may include an input device for detecting user input information, which may be, for example, a control instruction for ultrasonic transmission / reception timing, an operation input instruction for drawing points, lines or frames on an ultrasonic image, or other instruction types. The input device may include a keyboard, a mouse, a scroll wheel, a trackball, a mobile input device (such as a mobile device with a touch screen, a mobile phone, etc.), a multi-function knob, etc., or a combination of multiple thereof. The human-computer interaction device may also include an output device such as a printer.
[0036] The ultrasound imaging system 100 may further include a memory 124 for storing instructions executed by the processor, storing received ultrasound echoes, storing ultrasound images, etc. The memory may be a flash memory card, a solid-state memory, a hard disk, etc. It may be a volatile memory and / or a non-volatile memory, a removable memory and / or a non-removable memory, etc.
[0037] It should be understood that Figure 1 The components included in the ultrasonic imaging system 100 are only exemplary, and the ultrasonic imaging system 100 may include more or fewer components, and the present application is not limited thereto.
[0038] Refer to the following Figure 2 Describe the reperfusion data acquisition method for quantitative analysis of myocardial angiography proposed in the embodiment of the present application, Figure 2 2 is a schematic flow chart of a method 200 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application. Specifically, the method 200 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application is applied to Figure 1 The ultrasound imaging system 100 shown in the figure comprises an ultrasound probe 110 and a processor 116, wherein the processor 116 performs the following steps:
[0039] In step S210, electrocardiogram data is acquired, and a cardiac cycle is determined based on the electrocardiogram data;
[0040] In step S220, it is determined that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle;
[0041] In step S230, when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, the ultrasound probe is controlled to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubble, until the current moment reaches the time phase corresponding to the myocardial reperfusion starting point;
[0042] In step S240, the ultrasonic probe is controlled to transmit a second ultrasonic wave to the myocardium and receive a returned second ultrasonic echo signal;
[0043] In step S250, reperfusion data is generated based on the second ultrasound echo signal.
[0044] The reperfusion data acquisition method 200 for quantitative analysis of myocardial contrast imaging in the embodiment of the present application can make the starting point of each reperfusion after crushing be located near the selected phase when performing movie data acquisition for quantitative analysis of myocardial contrast imaging, so that the relationship between the reperfusion process and the cardiac phase can be controlled, and the movie data used for quantitative analysis can be standardized. When performing curve fitting in the process of quantitative analysis of myocardial contrast imaging, the fitting starting point and ending point can be automatically determined based on the crushing time data recorded when storing the movie, which simplifies the workflow and improves the user experience.
[0045] Before controlling the ultrasonic probe to transmit the first ultrasonic wave to the myocardium, the steps performed by the processor 116 also include: controlling the ultrasonic probe to transmit the third ultrasonic wave to the myocardium and receiving the returned third ultrasonic echo signal. Myocardial perfusion refers to injecting contrast agent into the body of the target object, and after the contrast agent reaches the heart, ultrasonic imaging of the heart is performed, and the blood supply state of the myocardium is judged according to the result of ultrasonic imaging. The contrast agent is a solution containing contrast microbubbles, which has high echogenicity, that is, the ability to reflect ultrasonic waves. There is a great difference between the echogenicity of the gas in the contrast microbubbles and that of human tissues. Therefore, the part containing contrast microbubbles can produce an ultrasonic image with high contrast due to the high echo difference. When the contrast agent is injected intravenously, the contrast agent enters various tissues and organs with the blood flow perfusion, so that the tissue imaging is enhanced. The myocardial perfusion process is the process of contrast agent perfusion into the myocardium, and the myocardial reperfusion process is to use a high mechanical index pulse (High MI Flash) to destroy the contrast microbubbles in the myocardium at a certain moment in the myocardial perfusion process, and continuously observe the filling-dissipation process of the contrast agent after this moment. The intensity of the high mechanical index pulse for destroying contrast microbubbles should be just enough to destroy the contrast microbubbles in the myocardium without destroying the microbubbles in the cardiac cavity. Generally, the mechanical index can be set between 0.8 and 1.2.
[0046] In one embodiment, based on Figure 1 The ultrasonic imaging system 100 shown performs ultrasonic scanning. During the scanning process, the transmitting circuit 112 sends a group of delayed and focused transmitting pulses to the ultrasonic probe 110 to stimulate the ultrasonic probe 110 to transmit ultrasonic waves to the myocardium containing contrast agent microbubbles. The receiving circuit 114 controls the ultrasonic probe 110 to receive the ultrasonic echo reflected by the target object and convert it into an electrical signal.
[0047] In step S210, ECG data is acquired, and a cardiac cycle is determined based on the ECG data. Specifically, ECG data containing multiple cardiac cycles is acquired through an ECG monitoring device. In an embodiment of the present application, a cardiac cycle can be represented by a period from one R wave end point to the next R wave end point, and further, the cardiac cycle is determined based on the average of the first m (m is a natural number and is greater than or equal to 1) cardiac cycles at the current moment, such as Figure 3A and 3B as shown in .
[0048] In step S220, it is determined that the contrast agent microbubble crushing start point and the myocardial reperfusion start point are located in the phase of the cardiac cycle, wherein the myocardial reperfusion start point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle.
[0049] In one embodiment, the characteristic point of the R wave may be any point in the R wave, such as the starting point of the R wave, the ending point of the R wave, or the peak point of the R wave. In one embodiment, the cardiac cycle may be calculated based on at least one cardiac cycle of the cardiac data collected before the current moment, and the phase of the contrast agent microbubble crushing starting point and the phase of the myocardial reperfusion starting point may be predicted based on the calculated cardiac cycle, or may be determined in real time based on the collected ECG data. The user's cardiac cycle will be updated with the user's actual heartbeat cycle.
[0050] Exemplarily, the method of determining the time phase in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the cardiac cycle comprises: determining the time phase in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the cardiac cycle based on the percentage value of the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point in the one cardiac cycle, and the cardiac cycle, wherein determining the percentage value of the myocardial reperfusion starting point in the one cardiac cycle comprises: determining the myocardial reperfusion starting point according to the percentage value of the characteristic point of the R wave of the cardiac cycle in the cardiac cycle.
[0051] In one embodiment, since the myocardium has a larger blood volume during diastole, contrast-enhanced fragmentation during diastole can more fully remove microbubbles in the myocardium. Meanwhile, in the field of quantitative analysis of myocardial contrast imaging, a cardiac cycle is often stored from the end point of an R wave to the end point of the next R wave. Figure 3A and 3B In the example, the phase corresponding to the characteristic point of the R wave (R wave corresponds to the end of diastole) is used as the starting point of myocardial reperfusion. At this time, the user sets the percentage value of the starting point of myocardial reperfusion in the phase in the cardiac cycle to 0%. If the user sets other phases in the cardiac cycle as the starting point of myocardial reperfusion, the user-set myocardial reperfusion starting point needs to be calculated based on the percentage values of other phases. For example, if the end of systole is desired as the starting point of myocardial reperfusion, the percentage value of the starting point of myocardial reperfusion in the phase in the cardiac cycle can be set to about 62.5%.
[0052] Exemplarily, the determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle includes: determining the phase of the characteristic point of the R wave; obtaining the phase corresponding to the characteristic point of the R wave of the current cardiac cycle or any cardiac cycle after the current cardiac cycle as the phase of the myocardial reperfusion starting point; using the phase corresponding to the first time length before the phase of the myocardial reperfusion starting point as the phase of the contrast agent microbubble crushing starting point.
[0053] In one embodiment, referring to Figure 3A and 3B As shown, when the phase corresponding to the characteristic point of the R wave is used as the starting point of myocardial reperfusion, the phase corresponding to the characteristic point of the R wave of the current cardiac cycle can be obtained as the starting point of myocardial reperfusion, and then the phase of the contrast agent microbubble crushing starting point is obtained according to the phase of the myocardial reperfusion starting point and the first duration (i.e., the duration of crushing the contrast agent microbubble).
[0054] Exemplarily, before controlling the ultrasound probe to transmit a first ultrasonic wave to the myocardium to break up the contrast agent microbubbles, the step executed by the processor further includes: responding to a first operation of a user for initiating the breaking up of the contrast agent microbubbles.
[0055] Exemplarily, when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, the ultrasound probe is controlled to transmit a first ultrasonic wave to the myocardium to crush the contrast agent microbubbles, including: when the time in response to the execution of the first operation is before the time phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, the ultrasound probe is controlled to transmit a first ultrasonic wave to the myocardium to crush the contrast agent microbubbles; when the time in response to the execution of the first operation is after the time phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point of at least the next cardiac cycle of the current cardiac cycle, the ultrasound probe is controlled to transmit a first ultrasonic wave to the myocardium to crush the contrast agent microbubbles.
[0056] In one embodiment, when the time phase of the contrast agent microbubble crushing starting point is obtained after the contrast agent microbubble crushing instruction is obtained, Figure 3A As shown, the time phase corresponding to the characteristic point of the R wave of the current cardiac cycle can be used as the starting point of myocardial reperfusion; and when the time phase of the contrast agent microbubble crushing starting point is obtained before the contrast agent microbubble crushing instruction is obtained, as shown Figure 3B As shown, the time phase corresponding to the characteristic point of the R wave of the current cardiac cycle cannot be used as the starting point of myocardial reperfusion. Therefore, the time phase corresponding to the characteristic point of the R wave of the cardiac cycle after the current cardiac cycle is further obtained as the starting point of myocardial reperfusion. The above operation is repeated to compare the obtained time phase of the contrast agent microbubble crushing starting point with the front and back positions of the contrast agent microbubble crushing instruction, until the time phase corresponding to the characteristic point of the R wave of the nth (n is a natural number, and greater than or equal to 1) cardiac cycle after the current cardiac cycle is confirmed as the time phase of the starting point of myocardial reperfusion.
[0057] Exemplarily, the method of determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle includes: obtaining the phase corresponding to the characteristic point of the R wave of the current cardiac cycle or any cardiac cycle after the current cardiac cycle as the phase of the contrast agent microbubble crushing starting point; based on the phases corresponding to the characteristic points of the n R waves after the phase of the contrast agent microbubble crushing starting point, determining the phase of the myocardial reperfusion starting point, wherein n is a natural number and is greater than or equal to 1.
[0058] In one embodiment, when the time phase corresponding to the characteristic point of the R wave is used as the contrast agent microbubble crushing starting point, the characteristic point of the R wave of the current cardiac cycle can be obtained as the contrast agent microbubble crushing starting point, or the time phase corresponding to the characteristic point of the R wave of any cardiac cycle after the current cardiac cycle (for example, the nth, where n is a natural number and greater than or equal to 1) can be obtained as the contrast agent microbubble crushing starting point, and the time phase of the myocardial reperfusion starting point can be obtained based on the contrast agent microbubble crushing starting point and the first time length (that is, the duration of crushing the contrast agent microbubble), and the time phase corresponding to the characteristic points of the n R waves after the contrast agent microbubble crushing starting point can be used as the time phase of the myocardial reperfusion starting point.
[0059] Furthermore, in the determined multiple cardiac cycles, the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are respectively determined in the phase of each cardiac cycle. In one embodiment, after the phase of the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point is determined in the current cardiac cycle or any cardiac cycle, it can be synchronized to the same phase or the closest phase in other cycles.
[0060] In step S230, when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point, the ultrasound probe is controlled to emit the first ultrasonic wave to the myocardium to crush the contrast agent microbubble, until the current moment reaches the phase corresponding to the myocardial reperfusion starting point, including: when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point in any cardiac cycle of the multiple cardiac cycles, the ultrasound probe is controlled to emit the first ultrasonic wave to the myocardium to crush the contrast agent microbubble. Specifically, controlling the ultrasound probe to emit the first ultrasonic wave to the myocardium to crush the contrast agent microbubble includes: controlling the ultrasound probe to emit the first ultrasonic wave with a power greater than a preset threshold to the myocardium to crush the contrast agent microbubble. Wherein, the power of the first ultrasonic wave is higher than the power of the third ultrasonic wave.
[0061] It should be noted that in the embodiment of the present application, when obtaining the contrast agent microbubble crushing instruction, if the current moment does not meet the crushing conditions, the ultrasound probe 110 is not immediately controlled to crush the contrast agent microbubbles, but waits until the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point, and then controls the ultrasound probe 110 to emit high-power ultrasound to crush the contrast agent microbubbles, such as Figure 3A and 3BAs shown. Controlling the ultrasonic probe 110 to crush the contrast agent microbubbles can be controlling the ultrasonic probe 110 to crush the contrast agent microbubbles in one cardiac cycle, or can be controlling the ultrasonic probe 110 to crush the contrast agent microbubbles in multiple cardiac cycles, and multiple reperfusions are performed, and corresponding perfusion data is obtained for each reperfusion. The standardization of the reperfusion process is achieved by controlling the actual contrast agent microbubble crushing starting point, that is, the user presses the microbubble crushing button only to express the intention to crush the contrast agent microbubbles, and the actual contrast agent microbubble crushing starting point is obtained by the method provided by the present application, and finally the myocardial reperfusion starting point is located near the contrast agent microbubble crushing starting point set by the user, thereby achieving the effect of standardization.
[0062] In step S240, the ultrasonic probe is controlled to transmit a second ultrasonic wave to the myocardium and receive a returned second ultrasonic echo signal. In one embodiment, as described above, the time phase of the myocardial reperfusion starting point can be obtained according to the contrast agent microbubble crushing starting point and the first duration (i.e., the duration of crushing the contrast agent microbubble), that is, the time phase of the myocardial reperfusion starting point is the time phase of the contrast agent microbubble crushing ending point, so when the current moment reaches the time phase corresponding to the myocardial reperfusion starting point, the ultrasonic probe is controlled to stop transmitting the first ultrasonic wave for crushing the contrast agent microbubble, and the ultrasonic probe is controlled to transmit the second ultrasonic wave to the target tissue containing the contrast agent microbubble and receive the returned second ultrasonic echo signal. The power of the first ultrasonic wave is higher than the power of the second ultrasonic wave, the power of the second ultrasonic wave and the power of the third ultrasonic wave can be the same or different, and the power of the first ultrasonic wave is higher than the power of the third ultrasonic wave.
[0063] In step S250, reperfusion data is generated based on the second ultrasound echo signal, wherein the reperfusion data includes ultrasound data corresponding to a plurality of cardiac cycles in the ultrasound echo signal.
[0064] Exemplarily, the method further includes the step of controlling the ultrasonic probe to stop transmitting the second ultrasonic wave to the myocardium. Exemplarily, the method of generating reperfusion data based on the second ultrasonic echo signal includes: determining the end point of myocardial reperfusion based on the time information of stopping transmitting the second ultrasonic wave to the myocardium; determining the reperfusion data from the ultrasonic data generated by the second ultrasonic echo signal and the third ultrasonic echo signal based on the myocardial reperfusion start point and the myocardial reperfusion end point. Exemplarily, the method of generating reperfusion data based on the second ultrasonic echo signal also includes: determining the end point of myocardial reperfusion based on the time information of stopping transmitting the second ultrasonic wave to the myocardium; determining the ultrasonic echo signal corresponding to reperfusion from the second ultrasonic echo signal based on the myocardial reperfusion start point and the myocardial reperfusion end point, and generating the reperfusion data based on the ultrasonic echo signal corresponding to the reperfusion.
[0065] In one embodiment, the ultrasound probe can be controlled to stop emitting the second ultrasound wave to the target tissue based on user interaction, such as by a trigger button or a UI interface. When the emission of the second ultrasound wave stops, it marks the end point of myocardial reperfusion.
[0066] In one embodiment, the duration of reperfusion can be determined based on electrocardiogram data (e.g., 3, 6, or 7 cardiac cycles) or the duration of reperfusion (e.g., 7 seconds, 8 seconds). The time to stop emitting the second ultrasonic wave to the target tissue can be determined based on the starting point of myocardial reperfusion and the duration of reperfusion. When the emission of the second ultrasonic wave stops, it marks the end point of myocardial reperfusion.
[0067] In one embodiment, after determining the end point of myocardial reperfusion, on the one hand, all ultrasonic echo signals obtained from the start point of myocardial perfusion to the end point of myocardial reperfusion can be processed to generate all ultrasonic data, and then ultrasonic data corresponding to reperfusion, i.e., reperfusion data, can be determined from the all ultrasonic data; on the other hand, ultrasonic echo signals corresponding to reperfusion can be first determined from the ultrasonic echo signals obtained from the start point of myocardial perfusion to the end point of myocardial reperfusion, and then the ultrasonic echo signal portion corresponding to reperfusion can be processed to generate reperfusion data. This application does not limit this.
[0068] In one embodiment, Figure 8 , a schematic diagram of a third ultrasonic echo signal, a first ultrasonic echo signal and a second ultrasonic echo signal obtained by sequentially transmitting a third ultrasonic wave, a first ultrasonic wave and a second ultrasonic wave is shown in FIG. It can be seen that the intensity of the first ultrasonic echo signal is significantly higher than that of the third ultrasonic echo signal and the second ultrasonic echo signal. Among them, the reperfusion data can be generated using the second ultrasonic echo signal. Since the third ultrasonic echo signal, the second ultrasonic echo signal and the first ultrasonic echo signal are not received separately when they are received, after receiving the above ultrasonic echo signals, a step of separating the second ultrasonic echo signal is also included. Specifically, the second ultrasonic echo signal can be determined based on the above ultrasonic echo signal and the myocardial reperfusion starting point to the myocardial reperfusion ending point, thereby determining the reperfusion data.
[0069] Further, after determining the reperfusion data based on the second ultrasonic echo signal, it also includes any one of the following items: storing the reperfusion data in the memory; storing the ultrasonic data obtained according to the first ultrasonic echo signal and the second ultrasonic echo signal in the memory, wherein the reperfusion data in the ultrasonic data and the data of the ultrasonic data other than the reperfusion data are stored separately; storing the ultrasonic data obtained according to the first ultrasonic echo signal, the second ultrasonic echo signal and the third ultrasonic echo signal in the memory.
[0070] After determining the reperfusion data, the method further includes a step of quantitatively analyzing the reperfusion data. Exemplarily, a time intensity curve is generated based on the reperfusion data or the ultrasound data corresponding to the ultrasound echo signal; a fitting parameter is determined based on the time intensity curve, wherein the fitting parameter includes one or more of the blood volume, blood flow velocity, and myocardial blood flow used to characterize the tissue. The ultrasound echo signal may include only the second ultrasound echo signal, or may include the first ultrasound echo signal and the second ultrasound echo signal, or may include the first ultrasound echo signal, the second ultrasound echo signal, and the third ultrasound echo signal.
[0071] In one embodiment, the beamforming module 112 performs corresponding delay and weighted sum processing on the reperfusion data or the ultrasound data corresponding to the ultrasound echo signal to achieve beamforming, and then sends the data to the processor 116. After some or all of the image post-processing steps such as denoising, smoothing, and enhancement, an ultrasound image during myocardial reperfusion is obtained. A region of interest is selected from the ultrasound image, and a time intensity curve is drawn by quantitative analysis of the region of interest in the ultrasound image. The formula C(t)=A×(1-e^ (-βt) ) fits the time intensity to obtain fitting parameters, wherein the fitting parameters include a parameter A for representing blood volume, a parameter β for representing blood flow velocity, and one or more of A×β for representing myocardial blood flow. Furthermore, a time intensity fitting curve can be generated based on the fitting parameters.
[0072] In one embodiment, the method further includes generating an ultrasonic image based on the second ultrasonic echo signal and the third ultrasonic echo signal, and / or generating an electrocardiogram based on the electrocardiogram data, wherein the electrocardiogram and the ultrasonic image are temporally associated.
[0073] In one embodiment, the method further includes generating an ultrasonic image based on the first ultrasonic echo signal, the second ultrasonic echo signal and the third ultrasonic echo signal, and / or generating an electrocardiogram based on the electrocardiogram data, wherein the electrocardiogram and the ultrasonic image are temporally associated.
[0074] Furthermore, the reperfusion data acquisition method for quantitative analysis of myocardial contrast provided by the present application further includes controlling a display to display the fitting parameters and / or the time intensity curve; and / or controlling a display to display the electrocardiogram and the ultrasound image; and / or controlling a display to display a mark indicating the starting point of myocardial reperfusion and / or the starting point of the contrast agent microbubble crushing. Figure 3A and 3B In the example shown, an electrocardiogram is shown, and the contrast agent microbubble crushing start point and the myocardial reperfusion start point are marked on the electrocardiogram.
[0075] According to the reperfusion data acquisition method for quantitative analysis of myocardial contrast provided in the present application, the reperfusion data is determined by determining that the starting point of contrast agent microbubble crushing and the starting point of myocardial reperfusion are located in the phase of the cardiac cycle, which facilitates subsequent data fitting and improves the consistency of evaluating myocardial perfusion.
[0076] Refer to the following Figure 4 Describe the reperfusion data acquisition method for quantitative analysis of myocardial angiography proposed in the embodiment of the present application, Figure 4 400 is a schematic flow chart of a method 400 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application. Specifically, the method 400 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application is applied to Figure 1 The ultrasound imaging system 100 shown in the figure comprises an ultrasound probe 110 and a processor 116, wherein the method comprises the following steps:
[0077] In step S410, obtaining ECG data;
[0078] In step S420, when the current moment reaches the first characteristic peak of the real-time ECG data, the ultrasound probe is controlled to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles, until the current moment reaches the kth characteristic peak of the real-time ECG data, where k is a natural number and k is greater than 1;
[0079] In step S430, the ultrasonic probe is controlled to transmit a second ultrasonic wave to the myocardium and receive a returned second ultrasonic echo signal;
[0080] In step S440, reperfusion data is determined based on the second ultrasound echo signal.
[0081] Before controlling the ultrasonic probe to transmit the first ultrasonic wave to the myocardium, the processor 116 may further execute the following steps: controlling the ultrasonic probe to transmit the third ultrasonic wave to the myocardium and receiving the returned third ultrasonic echo signal.
[0082] In step S410, real-time ECG data is acquired through an ECG monitoring device.
[0083] In step S420 and step S430, if Figure 5As shown, when the first characteristic peak (e.g., R wave) of the ECG data is reached at the current moment, by pressing a button or interacting with the UI interface, the ultrasound probe is controlled to emit a first ultrasonic wave to the target tissue containing contrast agent microbubbles to break the contrast agent microbubbles. Real-time ECG data is continuously acquired through the ECG monitoring device, and when the kth (k is a natural number, and k is greater than 1) characteristic peak of the ECG data is reached at the current moment, by pressing a button or interacting with the UI interface, the ultrasound probe is controlled to stop emitting the first ultrasonic wave for breaking the contrast agent microbubbles, and the ultrasound probe is controlled to emit a second ultrasonic wave to the target tissue containing contrast agent microbubbles and receive the returned ultrasonic echo signal.
[0084] Specifically, controlling the ultrasound probe to transmit a first ultrasonic wave to the myocardium to break up the contrast agent microbubbles includes: controlling the ultrasound probe to transmit the first ultrasonic wave with a power greater than a preset threshold to the myocardium to break up the contrast agent microbubbles. The power of the first ultrasonic wave is higher than the power of the third ultrasonic wave, the power of the first ultrasonic wave is higher than the power of the third ultrasonic wave, and the power of the second ultrasonic wave is the same as the power of the third ultrasonic wave.
[0085] In step S440, reperfusion data is determined based on the second ultrasonic echo signal. Since the third ultrasonic echo signal, the second ultrasonic echo signal, and the first ultrasonic echo signal are not received separately, after receiving the ultrasonic echo signal, the method further includes separating the second ultrasonic echo signal. Specifically, the reperfusion data can be determined based on the second ultrasonic echo signal with the time information corresponding to the kth characteristic peak of the ultrasonic echo signal and the real-time electrocardiogram data.
[0086] Further, a time intensity curve is generated based on the reperfusion data or based on the ultrasound data obtained according to the second ultrasound echo signal, and / or an ultrasound image is generated based on the second ultrasound echo signal and the third ultrasound echo signal, and / or an electrocardiogram is generated based on the electrocardiogram data, and the electrocardiogram and the ultrasound image are associated by time. In one embodiment, the display 118 is used to display the electrocardiogram and the ultrasound image; the display 118 is also used to display the position of the time for executing and / or ending the execution of the contrast agent microbubble crushing instruction. For example, in Figure 5 In the example shown, an electrocardiogram is shown, and the contrast agent microbubble crushing start point and the myocardial reperfusion start point are marked on the electrocardiogram.
[0087] Exemplarily, after determining the reperfusion data based on the ultrasonic echo signal and the time information of stopping crushing the contrast agent microbubbles, the memory 124 is also used to: store the reperfusion data in the memory; store the ultrasonic data obtained according to the second ultrasonic echo signal and the third ultrasonic echo signal in the memory, wherein the reperfusion data in the ultrasonic data and the data of the ultrasonic data other than the reperfusion data are stored separately; store the ultrasonic data obtained according to the first ultrasonic echo signal, the second ultrasonic echo signal and the third ultrasonic echo signal in the memory.
[0088] After determining the reperfusion data, the method further includes a step of quantitatively analyzing the reperfusion data. For example, a time intensity curve is generated based on the reperfusion data or the ultrasound data corresponding to the ultrasound echo signal. Further, the formula C(t)=A×(1-e^ (-βt) ) is used to fit the time intensity to obtain fitting parameters, wherein the fitting parameters include one or more of blood volume (A), blood flow velocity (β), and myocardial blood flow (A×β). In addition, a time intensity fitting curve can be generated based on the fitting parameters.
[0089] Refer to the following Figure 6 Describe the reperfusion data acquisition method for quantitative analysis of myocardial angiography proposed in the embodiment of the present application, Figure 6 600 is a schematic flow chart of a method 600 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application. Specifically, the method 600 for acquiring reperfusion data for quantitative analysis of myocardial angiography according to an embodiment of the present application is applied to Figure 1 The ultrasound imaging system 100 shown in the figure comprises an ultrasound probe 110 and a processor 116, wherein the method comprises the following steps:
[0090] In step S610, obtaining ECG data;
[0091] In step S620, at any time, the ultrasound probe is controlled to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles until the current time reaches the phase corresponding to the myocardial reperfusion starting point;
[0092] In step S630, the ultrasonic probe is controlled to transmit a second ultrasonic wave to the myocardium and receive a returned second ultrasonic echo signal;
[0093] In step S640, reperfusion data is determined based on the second ultrasound echo signal.
[0094] Before controlling the ultrasonic probe to transmit the first ultrasonic wave to the myocardium, the processor 116 may further execute the following steps: controlling the ultrasonic probe to transmit the third ultrasonic wave to the myocardium and receiving the returned third ultrasonic echo signal.
[0095] In step S610, real-time ECG data is acquired through an ECG monitoring device.
[0096] In step S620 and step S630, if Figure 7 As shown, at any time, by pressing a button or interacting with the UI interface, the ultrasound probe is controlled to emit a first ultrasonic wave to the target tissue containing contrast agent microbubbles to break the contrast agent microbubbles. Real-time ECG data is continuously acquired through the ECG monitoring device, and when the characteristic peak (e.g., R wave) of the ECG data is reached at the current time, by pressing a button or interacting with the UI interface, the ultrasound probe is controlled to stop emitting the first ultrasonic wave for breaking the contrast agent microbubbles, and the ultrasound probe is controlled to emit a second ultrasonic wave to the target tissue containing contrast agent microbubbles and receive the returned ultrasonic echo signal.
[0097] The specific description of step S640 may refer to the description of step S250 or step S440 above, which will not be repeated here.
[0098] The present application also provides a method for obtaining reperfusion data for quantitative analysis of myocardial angiography, which is applied to Figure 1 The ultrasound imaging system 100 shown in the figure comprises an ultrasound probe 110, a processor 116 and a display 118, wherein the display interface of the display 118 comprises a phase determination control and a microbubble crushing control, and the method comprises: acquiring electrocardiogram data, and determining the cardiac cycle based on the electrocardiogram data; in response to the operation of the phase determination control, determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle; in response to the operation of the microbubble crushing control, when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubbles until the current moment reaches the phase corresponding to the myocardial reperfusion starting point; controlling the ultrasound probe to transmit a second ultrasound wave to the myocardium and receiving a returned second ultrasound echo signal; and generating reperfusion data based on the second ultrasound echo signal.
[0099] The present application also provides an ultrasonic imaging system for implementing the above-mentioned method for acquiring reperfusion data for quantitative analysis of myocardial contrast. The ultrasonic imaging system includes an ultrasonic probe, a transmitting circuit, a receiving circuit, a processor and a display. Figure 1, the ultrasound imaging system can be implemented as follows Figure 1 The ultrasound imaging system 100 shown may include an ultrasound probe 110, a transmitting circuit 112, a receiving circuit 114, a processor 116 and a display 118. Optionally, the ultrasound imaging system 100 may also include a transmit / receive selection switch 120, a beamforming module 122 and a memory 124. The transmitting circuit 112 and the receiving circuit 114 may be connected to the ultrasound probe 110 via the transmit / receive selection switch 120. The relevant description of each component may refer to the relevant description above and will not be repeated here.
[0100] Among them, the transmitting circuit 112 is used to control the ultrasonic probe 110 to transmit ultrasonic waves to the target tissue; the receiving circuit 114 is used to control the ultrasonic probe 110 to receive the echo of the ultrasonic wave returned by the target tissue to obtain an ultrasonic echo signal; the processor 116 is used to perform ultrasonic imaging based on the ultrasonic echo signal; the processor 116 is also used to execute the steps of the above-mentioned reperfusion data acquisition method for quantitative analysis of myocardial contrast.
[0101] The above only describes the main functions of the components of the ultrasound imaging system. For more details, please refer to the relevant description of the reperfusion data acquisition method for quantitative analysis of myocardial contrast imaging, which will not be repeated here.
[0102] Although example embodiments have been described herein with reference to the accompanying drawings, it should be understood that the above example embodiments are merely exemplary and are not intended to limit the scope of the present application to this. Those of ordinary skill in the art may make various changes and modifications therein without departing from the scope and spirit of the present application. All these changes and modifications are intended to be included within the scope of the present application as required by the appended claims.
[0103] Those of ordinary skill in the art will appreciate that the units and algorithm steps of each example described in conjunction with the embodiments disclosed herein can be implemented in electronic hardware, or a combination of computer software and electronic hardware. Whether these functions are performed in hardware or software depends on the specific application and design constraints of the technical solution. Professional and technical personnel can use different methods to implement the described functions for each specific application, but such implementation should not be considered to be beyond the scope of this application.
[0104] In the several embodiments provided in this application, it should be understood that the disclosed devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic, for example, the division of the units is only a logical function division, and there may be other division methods in actual implementation, such as multiple units or components can be combined or integrated into another device, or some features can be ignored or not executed.
[0105] In the description provided herein, a large number of specific details are described. However, it is understood that the embodiments of the present application can be practiced without these specific details. In some instances, well-known methods, structures and techniques are not shown in detail so as not to obscure the understanding of this description.
[0106] Similarly, it should be understood that in order to streamline the present application and help understand one or more of the various inventive aspects, in the description of the exemplary embodiments of the present application, the various features of the present application are sometimes grouped together into a single embodiment, figure, or description thereof. However, the method of the present application should not be interpreted as reflecting the following intention: the claimed application requires more features than the features clearly stated in each claim. More specifically, as reflected in the corresponding claims, the inventive point is that the corresponding technical problem can be solved with features less than all the features of a single disclosed embodiment. Therefore, the claims following the specific embodiment are hereby explicitly incorporated into the specific embodiment, wherein each claim itself serves as a separate embodiment of the present application.
[0107] It will be understood by those skilled in the art that, except for mutually exclusive features, all features disclosed in this specification (including the accompanying claims, abstracts and drawings) and all processes or units of any method or device disclosed in this specification may be combined in any combination. Unless otherwise expressly stated, each feature disclosed in this specification (including the accompanying claims, abstracts and drawings) may be replaced by an alternative feature that provides the same, equivalent or similar purpose.
[0108] In addition, those skilled in the art will appreciate that, although some embodiments described herein include certain features included in other embodiments but not other features, the combination of features of different embodiments is meant to be within the scope of the present application and form different embodiments. For example, in the claims, any one of the claimed embodiments can be used in any combination.
[0109] The various component embodiments of the present application can be implemented in hardware, or in software modules running on one or more processors, or in a combination thereof. It should be understood by those skilled in the art that a microprocessor or digital signal processor (DSP) can be used in practice to implement some or all of the functions of some modules in the article analysis device according to the embodiment of the present application. The present application can also be implemented as a device program (e.g., computer program and computer program product) for executing part or all of the methods described herein. Such a program implementing the present application can be stored on a computer-readable medium, or can have the form of one or more signals. Such a signal can be downloaded from an Internet website, or provided on a carrier signal, or provided in any other form.
[0110] It should be noted that the above embodiments illustrate the present application rather than limit the present application, and that those skilled in the art may design alternative embodiments without departing from the scope of the appended claims. In the claims, any reference symbol between brackets should not be constructed as a limitation to the claims. The word "comprising" does not exclude the presence of elements or steps not listed in the claims. The word "one" or "an" preceding an element does not exclude the presence of multiple such elements. The present application may be implemented by means of hardware including several different elements and by means of a suitably programmed computer. In a unit claim that lists several devices, several of these devices may be embodied by the same hardware item. The use of the words first, second, and third, etc. does not indicate any order. These words may be interpreted as names.
[0111] The above is only a specific implementation or description of a specific implementation of the present application, and the protection scope of the present application is not limited thereto. Any technician familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed in the present application, which should be included in the protection scope of the present application. The protection scope of the present application shall be based on the protection scope of the claims.
Claims
1. A method for acquiring reperfusion data for quantitative analysis of myocardial angiography, characterized in that: Applied to an ultrasound imaging system, the myocardium contains contrast agent microbubbles, the ultrasound imaging system comprises an ultrasound probe and a processor, wherein the steps performed by the processor include: Acquiring electrocardiogram data, and determining a cardiac cycle based on the electrocardiogram data; Determine that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle; When the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to transmit a first ultrasonic wave to the myocardium to crush the contrast agent microbubble, until the current moment reaches the time phase corresponding to the myocardial reperfusion starting point; Controlling the ultrasonic probe to transmit a second ultrasonic wave to the myocardium and receiving a returned second ultrasonic echo signal; Reperfusion data is generated based on the second ultrasound echo signal.
2. The method according to claim 1, characterized in that Before controlling the ultrasound probe to transmit the first ultrasound wave to the myocardium, the steps performed by the processor further include: The ultrasonic probe is controlled to transmit a third ultrasonic wave to the myocardium and receive a returned third ultrasonic echo signal.
3. The method according to claim 2, characterized in that, The power of the first ultrasonic wave is higher than the power of the second ultrasonic wave, and the power of the first ultrasonic wave is higher than the power of the third ultrasonic wave.
4. The method according to claim 2, characterized in that The power of the second ultrasonic wave is the same as the power of the third ultrasonic wave.
5. The method according to claim 1, characterized in that One cardiac cycle represents the period from the end point of one R wave to the end point of the next R wave; The step of determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle comprises: Based on the percentage values of the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point in the one cardiac cycle and the cardiac cycle, the phases of the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point in the cardiac cycle are determined.
6. The method according to claim 5, characterized in that Determining the percentage value of the myocardial reperfusion starting point in the one cardiac cycle includes: The percentage value of the myocardial reperfusion starting point in the cardiac cycle is determined according to the percentage value of the characteristic point of the R wave of the cardiac cycle in the cardiac cycle.
7. The method according to claim 1, characterized in that The step of determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle comprises: Determining the phase of the characteristic point of the R wave; Acquire the time phase corresponding to the characteristic point of the R wave of the current cardiac cycle or any cardiac cycle after the current cardiac cycle as the time phase of the starting point of myocardial reperfusion; The time phase corresponding to the first time length before the time phase of the myocardial reperfusion starting point is used as the time phase of the contrast agent microbubble crushing starting point.
8. The method according to claim 1, characterized in that The step of determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle comprises: Acquire a time phase corresponding to a characteristic point of an R wave of a current cardiac cycle or any cardiac cycle after the current cardiac cycle as the time phase of a starting point of the contrast agent microbubble crushing; The phase of the myocardial reperfusion starting point is determined based on the phases corresponding to the characteristic points of n R waves after the phase of the contrast agent microbubble crushing starting point, where n is a natural number and is greater than or equal to 1.
9. The method according to any one of claims 1 to 8, characterized in that The step of determining that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle comprises: In multiple cardiac cycles, the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are respectively determined at the time phase of each cardiac cycle.
10. The method according to claim 9, characterized in that When the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubble comprises: When the current time reaches the time phase corresponding to the contrast agent microbubble crushing starting point in any cardiac cycle of the multiple cardiac cycles, the ultrasound probe is controlled to transmit the first ultrasound wave to the myocardium to crush the contrast agent microbubble.
11. The method according to any one of claims 1 to 8, characterized in that Controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles comprises: The ultrasonic probe is controlled to transmit the first ultrasonic wave with a power greater than a preset threshold to the myocardium to break up the contrast agent microbubbles.
12. The method according to any one of claims 2 to 4, characterized in that: The ultrasound imaging system includes a memory, and after generating the reperfusion data based on the second ultrasound echo signal, the processor further performs any one of the following steps: storing the reperfusion data in the memory; storing ultrasound data obtained according to the second ultrasound echo signal and the third ultrasound echo signal in the memory, wherein the reperfusion data in the ultrasound data and data other than the reperfusion data in the ultrasound data are stored separately; Ultrasonic data obtained according to the first ultrasonic echo signal, the second ultrasonic echo signal, and the third ultrasonic echo signal are stored in the memory.
13. The method according to any one of claims 1 to 8, characterized in that: The reperfusion data includes ultrasound data corresponding to a plurality of cardiac cycles in the second ultrasound echo signal.
14. The method according to any one of claims 1 to 8, characterized in that: The steps performed by the processor also include: A time intensity curve is generated based on the reperfusion data or based on ultrasound data obtained from the second ultrasound echo signal.
15. The method according to claim 14, characterized in that The ultrasound imaging system further includes a display, and the steps performed by the processor further include: Determining fitting parameters based on the time-intensity curve, wherein the fitting parameters include one or more of blood volume, blood flow velocity, and myocardial blood flow for characterizing tissue; The display is controlled to display the fitting parameters and / or the time intensity curve.
16. The method according to any one of claims 2 to 4, characterized in that: The ultrasound imaging system further includes a display, and the steps performed by the processor further include: Generate an ultrasonic image based on the second ultrasonic echo signal and the third ultrasonic echo signal, and / or generate an electrocardiogram based on the electrocardiogram data, wherein the electrocardiogram and the ultrasonic image are associated with each other through time; identify the myocardial reperfusion starting point and / or the contrast agent microbubble crushing starting point in the ultrasonic image and / or the electrocardiogram; The display is controlled to display the electrocardiogram and the ultrasound image, and / or the identification of the myocardial reperfusion starting point and / or the contrast agent microbubble crushing starting point.
17. The method according to any one of claims 1 to 8, characterized in that: The acquiring of electrocardiogram data and determining the cardiac cycle based on the electrocardiogram data includes: Electrocardiogram data including a plurality of cardiac cycles is acquired, and the cardiac cycle is determined based on an average value of m cardiac cycles before a current moment, where m is a natural number and is greater than or equal to 1.
18. The method according to any one of claims 2 to 8, characterized in that: The steps performed by the processor also include: controlling the ultrasonic probe to stop transmitting the second ultrasonic wave to the myocardium; The generating reperfusion data based on the second ultrasound echo signal comprises: determining a myocardial reperfusion end point based on time information of stopping transmitting the second ultrasonic wave to the myocardium; The reperfusion data is determined from ultrasound data generated from the second ultrasound echo signal and the third ultrasound echo signal based on the myocardial reperfusion start point and the myocardial reperfusion end point.
19. The method according to any one of claims 1 to 8, characterized in that: The steps performed by the processor also include: controlling the ultrasonic probe to stop transmitting the second ultrasonic wave to the myocardium; The generating reperfusion data based on the second ultrasound echo signal comprises: determining a myocardial reperfusion end point based on time information of stopping transmitting the ultrasonic wave to the myocardium; Based on the myocardial reperfusion start point and the myocardial reperfusion end point, an ultrasonic echo signal corresponding to reperfusion is determined from the second ultrasonic echo signal, and the reperfusion data is generated based on the ultrasonic echo signal corresponding to reperfusion.
20. The method according to claim 18 or 19, characterized in that The controlling the ultrasonic probe to stop transmitting the second ultrasonic wave to the myocardium comprises: According to the interactive operation of the user, the ultrasound probe is controlled to stop transmitting the second ultrasound wave to the myocardium.
21. The method according to claim 18 or 19, characterized in that The controlling the ultrasonic probe to stop transmitting the second ultrasonic wave to the myocardium comprises: Determining a time to stop transmitting the second ultrasonic wave to the myocardium according to the electrocardiogram data or the reperfusion duration; When the current time reaches the time to stop transmitting the second ultrasonic wave to the myocardium, the ultrasonic probe is controlled to stop transmitting the second ultrasonic wave to the myocardium.
22. The method according to any one of claims 1 to 8, characterized in that Before controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles, the steps performed by the processor further include: In response to a first operation of a user for initiating the crushing of the contrast agent microbubbles.
23. The method of claim 22, wherein: When the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, controlling the ultrasound probe to emit a first ultrasound wave to the myocardium to crush the contrast agent microbubble includes: When the time of executing the first operation is before the phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to crush the contrast agent microbubble; When the time of execution of the first operation is after the phase corresponding to the contrast agent microbubble crushing starting point of the current cardiac cycle, when the current moment reaches the phase corresponding to the contrast agent microbubble crushing starting point of at least the next cardiac cycle of the current cardiac cycle, the ultrasound probe is controlled to emit a first ultrasonic wave to the myocardium to crush the contrast agent microbubbles.
24. A method for acquiring reperfusion data for quantitative analysis of myocardial angiography, characterized in that: Applied to an ultrasound imaging system, the myocardium contains contrast agent microbubbles, the ultrasound imaging system includes an ultrasound probe and a processor, and the steps performed by the processor include: Obtain ECG data; When the first characteristic peak of the electrocardiogram data is reached at the current moment, the ultrasonic probe is controlled to transmit a first ultrasonic wave to the myocardium to break up the contrast agent microbubbles, until the kth characteristic peak of the electrocardiogram data is reached at the current moment, where k is a natural number and is greater than 1; Controlling the ultrasonic probe to transmit a second ultrasonic wave to the myocardium and receiving a returned second ultrasonic echo signal; Reperfusion data is determined based on the second ultrasound echo signal.
25. The method of claim 24, wherein: Before controlling the ultrasound probe to transmit the first ultrasound wave to the myocardium, the steps performed by the processor further include: The ultrasonic probe is controlled to transmit a third ultrasonic wave to the myocardium and receive a returned third ultrasonic echo signal.
26. The method of claim 25, wherein: The power of the first ultrasonic wave is higher than the power of the second ultrasonic wave, and the power of the first ultrasonic wave is higher than the power of the third ultrasonic wave.
27. The method according to any one of claims 24 to 26, characterized in that Controlling the ultrasound probe to transmit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles comprises: The ultrasonic probe is controlled to transmit the first ultrasonic wave with a power greater than a preset threshold to the myocardium to break up the contrast agent microbubbles.
28. The method according to claim 25 or 26, characterized in that After determining the reperfusion data based on the ultrasound echo signal and the time information of stopping crushing the contrast agent microbubbles, the steps performed by the processor further include any one of the following: storing the reperfusion data in the memory; storing ultrasound data obtained according to the second ultrasound echo signal and the third ultrasound echo signal in the memory, wherein the reperfusion data in the ultrasound data and data other than the reperfusion data in the ultrasound data are stored separately; Ultrasonic data obtained according to the first ultrasonic echo signal, the second ultrasonic echo signal, and the third ultrasonic echo signal are stored in the memory.
29. The method according to any one of claims 24 to 26, characterized in that The steps performed by the processor also include: A time intensity curve is generated based on the reperfusion data or based on ultrasound data obtained from the second ultrasound echo signal.
30. The method according to claim 25 or 26, characterized in that The steps performed by the processor also include: Generate an ultrasonic image based on the second ultrasonic echo signal and the third ultrasonic echo signal, and / or generate an electrocardiogram based on the electrocardiogram data, wherein the electrocardiogram and the ultrasonic image are associated with each other through time; identify the myocardial reperfusion starting point and / or the contrast agent microbubble crushing starting point in the ultrasonic image and / or the electrocardiogram; The display is controlled to display the electrocardiogram and the ultrasound image, and / or the identification of the myocardial reperfusion starting point and / or the contrast agent microbubble crushing starting point.
31. A method for acquiring reperfusion data for quantitative analysis of myocardial angiography, characterized in that: Applied to an ultrasound imaging system, the myocardium contains contrast agent microbubbles, the ultrasound imaging system comprises an ultrasound probe and a processor, wherein the steps performed by the processor include: Obtain ECG data; At any time, the ultrasound probe is controlled to emit a first ultrasound wave to the myocardium to break up the contrast agent microbubbles until the time phase corresponding to the myocardial reperfusion starting point is reached at the current time; Controlling the ultrasonic probe to transmit a second ultrasonic wave to the myocardium and receiving a returned second ultrasonic echo signal; Reperfusion data is determined based on the second ultrasound echo signal.
32. The method of claim 31, wherein: The obtaining of ECG data includes: obtaining real-time ECG data; The time phase corresponding to the myocardial reperfusion starting point reached at the current moment includes: a characteristic point of the R wave of the real-time electrocardiogram data reached at the current moment.
33. A method for acquiring reperfusion data for quantitative analysis of myocardial angiography, characterized in that: Applied to an ultrasound imaging system, the myocardium contains contrast agent microbubbles, the ultrasound imaging system includes an ultrasound probe, a processor and a display, the display interface of the display includes a microbubble crushing control, and the steps performed by the processor include: Acquiring electrocardiogram data, and determining a cardiac cycle based on the electrocardiogram data; Determine that the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are located in the phase of the cardiac cycle, wherein the myocardial reperfusion starting point is determined according to the phase corresponding to the characteristic point of the R wave of the cardiac cycle; In response to the operation of the microbubble crushing control, when the current moment reaches the time phase corresponding to the contrast agent microbubble crushing starting point, the ultrasound probe is controlled to transmit a first ultrasonic wave to the myocardium to crush the contrast agent microbubble, until the current moment reaches the time phase corresponding to the myocardial reperfusion starting point; Controlling the ultrasonic probe to transmit a second ultrasonic wave to the myocardium and receiving a returned second ultrasonic echo signal; Reperfusion data is generated based on the second ultrasound echo signal.
34. The method of claim 33, wherein: The display interface of the display also includes a phase determination control. In response to the operation of the phase determination control, the phase of the cardiac cycle in which the contrast agent microbubble crushing starting point and the myocardial reperfusion starting point are determined.
35. An ultrasonic imaging system, characterized in that: include: Ultrasound probe; A transmitting circuit, used for stimulating the ultrasonic probe to transmit ultrasonic waves to the myocardium; A receiving circuit, used for controlling the ultrasonic probe to receive the ultrasonic echo to obtain the ultrasonic echo signal; A processor for executing the steps of the reperfusion data acquisition method for quantitative analysis of myocardial contrast according to any one of claims 1-34.
